Biosimilar Insights
-
Cytiva's Aseptic Filling Workcell User Group
1/9/2026
Discover how global collaboration among aseptic filling experts is driving innovation and improving operations.
-
Doubling Up For Speed In Biomanufacturing
12/12/2025
Accelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.
-
CDMO Or No CDMO... That Is The Question
12/12/2025
Success depends on assessing internal capabilities and knowing when outsourcing can accelerate timelines. Learn how strategic decisions reduce risk, avoid costly delays, and keep your organization competitive.
-
Choosing The Best mRNA Manufacturing Strategy
12/12/2025
Choosing the right mRNA manufacturing model can define your success. Learn how to weigh control, cost, and flexibility to build a strategy that supports innovation and long-term growth.
-
How To Reduce Batch Loss In Biopharma Production
12/12/2025
Batch failures in biopharma remain costly despite improvements. Learn the leading causes in downstream purification and how supplier expertise can help reduce risk and protect production.
-
CDMOs - Key Collaborators In Streamlining Drug Development
12/12/2025
Accelerating biologics development requires more than speed. Discover how the right CDMO partnership can streamline processes and help you reach the market faster without sacrificing control.
-
Scaling Up Bioprocesses Through A CDMO
12/12/2025
Scaling biopharma processes is complex. Learn how flexibility, single-use systems, and strategic partnerships are helping manufacturers overcome these challenges and accelerate time to market.
-
Lentiviral Vector Upstream Process
12/12/2025
Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.
-
5 Reasons For Outsourcing Chromatography Resin Lifetime Studies
12/12/2025
Outsourcing resin lifetime studies accelerates timelines, reduces costs, and minimizes risk. Gain expert support, free up resources, and optimize resin performance without tying up your team or equipment.
-
Is Your Biologics CDMO Transparent?
12/12/2025
Transparency and collaboration with a CDMO are vital for reducing risk and protecting IP. Discover four essential practices, from clear communication to IP safeguards, that help build trust.